AAG
RMD icon

Armstrong Advisory Group’s ResMed RMD Stock Holding History

Armstrong Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75K Sell
9
-18
-67% -$3.73K ﹤0.01% 917
2026
Q1 		$6.06K Hold
27
– – ﹤0.01% 768
2025
Q4 		$6.5K Sell
27
-19
-41% -$4.86K ﹤0.01% 746
2025
Q3 		$12.6K Buy
46
+1
+2% +$273 ﹤0.01% 639
2025
Q2 		$11.6K Buy
+45
New +$10.7K ﹤0.01% 639

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Armstrong Advisory Group's RMD Position: Q2 2026 in Review

Armstrong Advisory Group reduced its ResMed (RMD) stake by 67% in Q2 2026, selling an estimated $3.73K and leaving 9 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Armstrong Advisory Group first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $12.6K in Q3 2025. 113 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Armstrong Advisory Group held 9 shares of ResMed worth $1.75K as of Q2 2026.
  • Armstrong Advisory Group sold 18 ResMed shares in Q2 2026, an estimated $3.73K.
  • ResMed made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #917 holding.
  • Armstrong Advisory Group first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • Armstrong Advisory Group's ResMed position peaked at $12.6K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.